| Literature DB >> 29630478 |
Aviseka Acharya1, Sonja Brungs2, Margit Henry1, Tamara Rotshteyn1, Nirmala Singh Yaduvanshi1, Lucia Wegener2, Simon Jentzsch2, Jürgen Hescheler1, Ruth Hemmersbach2, Helene Boeuf3, Agapios Sachinidis1.
Abstract
Embryonic developmental studies under microgravity conditions in space are very limited. To study the effects of short-term altered gravity on embryonic development processes, we exposed mouse embryonic stem cells (mESCs) to phases of hypergravity and microgravity and studied the differentiation potential of the cells using wide-genome microarray analysis. During the 64th European Space Agency's parabolic flight campaign, mESCs were exposed to 31 parabolas. Each parabola comprised phases lasting 22 s of hypergravity, microgravity, and a repeat of hypergravity. On different parabolas, RNA was isolated for microarray analysis. After exposure to 31 parabolas, mESCs (P31 mESCs) were further differentiated under normal gravity (1 g) conditions for 12 days, producing P31 12-day embryoid bodies (EBs). After analysis of the microarrays, the differentially expressed genes were analyzed using different bioinformatic tools to identify developmental and nondevelopmental biological processes affected by conditions on the parabolic flight experiment. Our results demonstrated that several genes belonging to GOs associated with cell cycle and proliferation were downregulated in undifferentiated mESCs exposed to gravity changes. However, several genes belonging to developmental processes, such as vasculature development, kidney development, skin development, and to the TGF-β signaling pathway, were upregulated. Interestingly, similar enriched and suppressed GOs were obtained in P31 12-day EBs compared with ground control 12-day EBs. Our results show that undifferentiated mESCs exposed to alternate hypergravity and microgravity phases expressed several genes associated with developmental/differentiation and cell cycle processes, suggesting a transition from the undifferentiated pluripotent to a more differentiated stage of mESCs.Entities:
Keywords: differentiation; embryonic stem cells; hypergravity; microgravity; parabolic flight; transcriptomics
Mesh:
Year: 2018 PMID: 29630478 PMCID: PMC5995265 DOI: 10.1089/scd.2017.0294
Source DB: PubMed Journal: Stem Cells Dev ISSN: 1547-3287 Impact factor: 3.272

Experimental scheme for parabolic flight experiment. (A) An incubator was filled with T75 cell culture flasks, connected to syringes filled with RNA later in a fixation unit on top of the incubator. The syringes were manually operated from outside the incubator, injecting RNA later into the flasks at appropriate time points (before P0 and after P31). (B) Flight maneuver time points during the campaign and RNA later sample fixation points. Color images available online at www.liebertpub.com/scd

Analysis of the differentially expressed genes in undifferentiated and differentiated mESCs under variable gravity conditions. (A) The 3D-PCA carried out using TAC4.0 software (Affymetrix) based on the limma R/Bioconductor software package for integrative analysis of large scale gene expression data. Deregulated gene expression structure of transcriptome data sets was dimensionality-reduced and presented in the form of a 3D-PCA diagram. As expected, there were large differences between GC and FC mESCs, as well as GC 12-day and P31 12-day EBs. PCA1 illustrates a relatively large distance between GC and FC mESCs, and P31 mESCs. Small differences between GC 12-day EBs and P31 12-day EBs were observed, indicating lower numbers of differentially expressed genes in mESCs exposed to 31 parabolas and differentiated for 12 days under 1 g conditions. (B) Number of differentially expressed genes in undifferentiated and 12-day differentiated EBs under variable gravity conditions. The differentially expressed genes (<2-fold change in downregulated or >2-fold change in upregulated genes; P < 0.05) were identified by analyzing the CEL files using TAC4.0 and the ebayes (limma) gene expression analysis settings. mESCs, mouse embryonic stem cells. EB, embryoid body; GC and FC mESC, ground control and flight control mESC; PCA, Principle Component Analysis. Color images available online at www.liebertpub.com/scd
Parent and Child Term GOs and KEGG Pathways Specifically Enriched into Mouse Embryonic Stem Cells After 31 Parabolas (P31 mESCs) in Comparison to Mouse Embryonic Stem Cells Before the Parabolas (FC mESCs)
| P | |||
|---|---|---|---|
| GO:0001568∼blood vessel development | 18 | 0.01612 | 5.68 |
| GO:0001649∼osteoblast differentiation | 8 | 0.04935 | 2.21 |
| GO:0001822∼kidney development | 12 | 0.00569 | 3.79 |
| GO:0001890∼placenta development | 10 | 0.00128 | 3.15 |
| GO:0001942∼hair follicle development | 7 | 0.00426 | 0.95 |
| GO:0001944∼vasculature development | 18 | 0.02578 | 5.68 |
| GO:0003007∼heart morphogenesis | 9 | 0.04182 | 2.84 |
| GO:0005783∼endoplasmic reticulum | 51 | 2.25E-06 | 16.09 |
| GO:0005789∼endoplasmic reticulum membrane | 36 | 1.02E-06 | 11.36 |
| GO:0006915∼apoptotic process | 37 | 0.03643 | 11.67 |
| GO:0007423∼sensory organ development | 16 | 0.04056 | 5.05 |
| GO:0009887∼organ morphogenesis | 29 | 0.00177 | 9.15 |
| GO:0009967∼positive regulation of signal transduction | 29 | 0.04019 | 9.15 |
| GO:0014031∼mesenchymal cell development | 7 | 0.04559 | 2.21 |
| GO:0021915∼neural tube development | 8 | 0.02357 | 2.52 |
| GO:0030097∼hemopoiesis | 24 | 0.00769 | 7.57 |
| GO:0030510∼regulation of BMP signaling pathway | 5 | 0.0398 | 1.58 |
| GO:0034660∼ncRNA metabolic process | 14 | 0.01388 | 4.42 |
| GO:0043588∼skin development | 14 | 2.81E-04 | 4.42 |
| GO:0045646∼regulation of erythrocyte differentiation | 4 | 0.02459 | 1.26 |
| GO:0045667∼regulation of osteoblast differentiation | 7 | 0.01484 | 2.21 |
| GO:0048513∼animal organ development | 83 | 8.99E-06 | 26.18 |
| GO:0048568∼embryonic organ development | 20 | 1.65E-04 | 6.31 |
| GO:0048598∼embryonic morphogenesis | 17 | 0.03431 | 5.36 |
| GO:0060538∼skeletal muscle organ development | 8 | 0.03006 | 2.52 |
| GO:0061458∼reproductive system development | 17 | 0.00323 | 5.36 |
| GO:0070059∼intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 5 | 0.01161 | 1.58 |
| GO:0072358∼cardiovascular system development | 25 | 0.02809 | 7.89 |
| GO:0097190∼apoptotic signaling pathway | 16 | 0.02863 | 5.05 |
| GO:2001233∼regulation of apoptotic signaling pathway | 13 | 0.01253 | 4.10 |
| GO:2001235∼positive regulation of apoptotic signaling pathway | 7 | 0.04347 | 2.21 |
| GO:2001236∼regulation of extrinsic apoptotic signaling pathway | 7 | 0.03395 | 2.21 |
| mmu00531:Glycosaminoglycan degradation | 4 | 0.00181 | 1.26 |
| mmu04350:TGF-beta signaling pathway | 7 | 4.71E-04 | 2.21 |
Parent and Child GO Terms and KEGG Pathways Specifically Suppressed in Mouse Embryonic Stem Cells After 31 Parabolas (P31 mESCs) Compared with Mouse Embryonic Stem Cells Before the Parabolas (FC mESCs)
| P | |||
|---|---|---|---|
| GO:0000070∼mitotic sister chromatid segregation | 43 | 3.10E-14 | 2.39 |
| GO:0000075∼cell cycle checkpoint | 43 | 1.84E-09 | 2.39 |
| GO:0000086∼G2/M transition of mitotic cell cycle | 21 | 1.35E-05 | 1.17 |
| GO:0000281∼mitotic cytokinesis | 10 | 0.001976 | 0.56 |
| GO:0005634∼nucleus | 899 | 1.04E-52 | 49.94 |
| GO:0005643∼nuclear pore | 15 | 0.0026653 | 0.83 |
| GO:0005730∼nucleolus | 158 | 5.92E-17 | 8.78 |
| GO:0006396∼RNA processing | 151 | 1.22E-23 | 8.39 |
| GO:0006406∼mRNA export from nucleus | 14 | 9.51E-05 | 0.78 |
| GO:0006915∼apoptotic process | 193 | 1.41E-04 | 10.72 |
| GO:0007094∼mitotic spindle assembly checkpoint | 10 | 8.54E-05 | 0.56 |
| GO:0007346∼regulation of mitotic cell cycle | 77 | 1.27E-10 | 4.28 |
| GO:0008631∼intrinsic apoptotic signaling pathway in response to oxidative stress | 8 | 0.0476467 | 0.44 |
| GO:0010468∼regulation of gene expression | 570 | 2.04E-37 | 31.67 |
| GO:0016571∼histone methylation | 28 | 6.89E-06 | 1.56 |
| GO:0032007∼negative regulation of TOR signaling | 8 | 0.0247236 | 0.44 |
| GO:0032774∼RNA biosynthetic process | 480 | 6.73E-31 | 26.67 |
| GO:0043069∼negative regulation of programmed cell death | 110 | 5.44E-04 | 6.11 |
| GO:0043484∼regulation of RNA splicing | 34 | 5.22E-11 | 1.89 |
| GO:0044770∼cell cycle phase transition | 62 | 3.66E-08 | 3.44 |
| GO:0051028∼mRNA transport | 33 | 1.12E-10 | 1.83 |
| GO:0051225∼spindle assembly | 23 | 1.75E-06 | 1.28 |
| GO:0090068∼positive regulation of cell cycle process | 42 | 1.73E-07 | 2.33 |
| GO:0097193∼intrinsic apoptotic signaling pathway | 37 | 0.0057664 | 2.07 |
| GO:1901991∼negative regulation of mitotic cell cycle phase transition | 28 | 1.88E-06 | 1.56 |
| GO:1902036∼regulation of hematopoietic stem cell differentiation | 4 | 0.0161565 | 0.22 |
| GO:1902749∼regulation of cell cycle G2/M phase transition | 17 | 1.56E-04 | 0.94 |
| GO:1903047∼mitotic cell cycle process | 142 | 2.74E-23 | 7.89 |
| GO:2001020∼regulation of response to DNA damage stimulus | 29 | 1.45E-04 | 1.61 |
| GO:2001141∼regulation of RNA biosynthetic process | 468 | 1.69E-30 | 26.00 |
| mmu03013:RNA transport | 36 | 1.24E-08 | 2.00 |
| mmu03015:mRNA surveillance pathway | 24 | 2.39E-07 | 1.33 |
| mmu04010:MAPK signaling pathway | 29 | 0.0166413 | 1.61 |
| mmu04110:Cell cycle | 24 | 2.47E-05 | 1.33 |
| mmu04115:p53 signaling pathway | 12 | 0.0084450 | 0.67 |
| mmu04910:Insulin signaling pathway | 18 | 0.0251697 | 1.00 |
| mmu04915:Estrogen signaling pathway | 14 | 0.0247794 | 0.78 |
| mmu04922:Glucagon signaling pathway | 14 | 0.028742 | 0.78 |

Expression of the pluripotent factors in GC mESCs, GC 12-day EBs, FC mESCs, P31 12-day EBs, and in FC mESCs versus P31 mESCs (n = 3; microarray expression values derived from three independent parabolic flights, executed over 3 days; P < 0.05 for mESCs vs. 12-day EBs). Color images available online at www.liebertpub.com/scd
GOs Specifically Enriched in Mouse Embryonic Stem Cells Exposed to 31 Parabolas and Differentiated for 12 Days Under 1-
| P | |||
|---|---|---|---|
| GO:0010468∼regulation of gene expression | 92 | 2.49E-09 | 31.51 |
| GO:0048468∼cell development | 61 | 2.88E-09 | 20.89 |
| GO:0016070∼RNA metabolic process | 90 | 2.88E-08 | 30.82 |
| GO:0048732∼gland development | 23 | 1.39E-07 | 7.88 |
| GO:0022008∼neurogenesis | 41 | 1.50E-05 | 14.04 |
| GO:0010628∼positive regulation of gene expression | 40 | 8.63E-05 | 13.70 |
| GO:0030182∼neuron differentiation | 33 | 3.07E-04 | 11.30 |
| GO:0006915∼apoptotic process | 39 | 4.16E-04 | 13.36 |
| GO:0043067∼regulation of programmed cell death | 34 | 6.19E-04 | 11.64 |
| GO:0016358∼dendrite development | 11 | 7.19E-04 | 3.77 |
| GO:0061458∼reproductive system development | 16 | 0.001131047 | 5.48 |
| GO:0045444∼fat cell differentiation | 10 | 0.001152154 | 3.42 |
| GO:0004672∼protein kinase activity | 18 | 0.001432929 | 6.16 |
| GO:0001825∼blastocyst formation | 5 | 0.001822467 | 1.71 |
| GO:0060548∼negative regulation of cell death | 25 | 0.002020882 | 8.56 |
| GO:0030879∼mammary gland development | 8 | 0.00226657 | 2.74 |
| GO:0007281∼germ cell development | 12 | 0.002593612 | 4.11 |
| GO:0061053∼somite development | 6 | 0.005103724 | 2.05 |
| GO:0001501∼skeletal system development | 14 | 0.008336702 | 4.79 |
| GO:0008406∼gonad development | 9 | 0.012011842 | 3.08 |
| GO:0008631∼intrinsic apoptotic signaling pathway in response to oxidative stress | 4 | 0.012651921 | 1.37 |
| GO:0007283∼spermatogenesis | 15 | 0.013400423 | 5.14 |
| GO:0060541∼respiratory system development | 9 | 0.015552787 | 3.08 |
| GO:0009952∼anterior/posterior pattern specification | 8 | 0.017554488 | 2.74 |
| GO:0072074∼kidney mesenchyme development | 3 | 0.019887064 | 1.03 |
| GO:0001568∼blood vessel development | 15 | 0.025574845 | 5.14 |
| GO:0007179∼transforming growth factor beta receptor signaling pathway | 6 | 0.029268965 | 2.05 |
| GO:0043586∼tongue development | 3 | 0.034207515 | 1.03 |
| GO:0001889∼liver development | 6 | 0.042352299 | 2.05 |
| GO:0009880∼embryonic pattern specification | 4 | 0.044904479 | 1.37 |
| GO:0048839∼inner ear development | 7 | 0.045708507 | 2.40 |
GOs Specifically Suppressed in Mouse Embryonic Stem Cells Exposed to 31 Parabolas and Differentiated for 12 Days Under 1-
| P | |||
|---|---|---|---|
| GO:0044267∼cellular protein metabolic process | 27 | 3.12E-04 | 45.76 |
| GO:0006915∼apoptotic process | 15 | 6.28E-04 | 25.42 |
| GO:0016310∼phosphorylation | 14 | 0.007339259 | 23.73 |
| GO:0005925∼focal adhesion | 6 | 0.008186175 | 10.17 |
| GO:0035556∼intracellular signal transduction | 15 | 0.00961423 | 25.42 |
| GO:0055002∼striated muscle cell development | 4 | 0.012606213 | 6.78 |
| GO:0055001∼muscle cell development | 4 | 0.016495658 | 6.78 |
| GO:0006508∼proteolysis | 11 | 0.017068186 | 18.64 |
| GO:0000165∼MAPK cascade | 7 | 0.017651182 | 11.86 |
| GO:0060047∼heart contraction | 4 | 0.018011943 | 6.78 |
| GO:0023014∼signal transduction by protein phosphorylation | 7 | 0.018108933 | 11.86 |
| GO:0055013∼cardiac muscle cell development | 3 | 0.023377587 | 5.08 |
| GO:0055006∼cardiac cell development | 3 | 0.026239123 | 5.08 |
| GO:0055017∼cardiac muscle tissue growth | 3 | 0.02802094 | 5.08 |
| GO:0060419∼heart growth | 3 | 0.03236142 | 5.08 |
| GO:0048738∼cardiac muscle tissue development | 4 | 0.032510032 | 6.78 |
| GO:0014706∼striated muscle tissue development | 5 | 0.036231052 | 8.47 |
| GO:0060548∼negative regulation of cell death | 8 | 0.036790061 | 13.56 |
| GO:0050684∼regulation of mRNA processing | 3 | 0.038986259 | 5.08 |
| GO:0070371∼ERK1 and ERK2 cascade | 4 | 0.0458714 | 6.78 |